2m 2m 2m 2m 2m 2m 2m
Embecta (EMBC)
NASDAQ
$5.09+$0.15 (+2.96%)
Price as of Sep 11, 2026 7:56 PM EDT- $277.1MMarket Cap
- -66.00%1-Year Change
- Medical Instruments & SuppliesIndustry
Embecta (EMBC)
$5.09+$0.15 (+2.96%)
EMBC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.94 | ||
Change | +$0.05 (+1.02%) | ||
Open | $4.93 | ||
High | $5.04 | ||
Low | $4.89 | ||
Previous Close | $4.89 | ||
Volume | 1,133,390 | ||
30-Day Average Volume | 1,442,985 | ||
1-Week Change | -14.83% | ||
1-Month Change | 1.43% | ||
1-Year Change | -66.00% | ||
3-Year Change | -65.70% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 56.7M | ||
Total Assets | $1.3B | ||
Market Cap | $277.1M | ||
Enterprise Value | $1.5B | ||
Period: QTR TTM FY | |||
Revenue | $271.7M | ||
Net Income | $21.1M | ||
Free Cash Flow | $40.7M | ||
EBIT | $51.5M | ||
EBITDA | $62.1M | ||
Net Working Capital | $285.3M | ||
EPS | $0.36 | ||
Enterprise Value/EBITDA | 24 | ||
Enterprise Value/Revenue | 6 | ||
P/B | -0 | ||
P/E | 14 | ||
PEG | 0 | ||
Price/Free Cash Flow | 7 | ||
Price/Operating Cash Flow | 7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 0.81% | ||
Trailing Annual Dividend Yield | 6.48% | ||
Ex-Dividend Date | 08/27/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield